Infectious Disease Flashcards
Sporotrichosis
The initial lesion of lymphocutaneous sporotrichosis is a reddish nodule that later ulcerates and appears at the site of a thorn prick or other skin injury.
From the site of inoculation, the fungus spreads along the lymphatics forming additional subcutaneous nodules and ulcers.
Definitive diagnosis is made by culture,
Itraconazole is the drug of choice for treatment
Disseminated gonococcal infection
Manifestation
Purulent monoarthritis
OR
Triad of tenosynovitis, dermatitis, migratory polyarthralgia
Diagnosis
A)Detection of Neisseria gonorrhoeae in urine, cervical, or urethralsample
B)Culture of blood, synovial fluid (less sensitive)
Treatment
3rd-generation cephalosporin intravenously
Meningitis exposure prophylaxis
Regardless of vaccination status, healthcare workers (with close proximity and prolonged duration or exposure to respiratory secretions) and close contacts of infected patients with meningococcal disease should receive antibiotic chemoprophylaxis, ideally within the first 24 hours of patient diagnosis. Recommended regimens include rifampin, ciprofloxacin, or ceftriaxone
Lemmiere’s syndrome
Signs and symptoms
-Recent sore throat
-Persistent fever and systemic symptoms while taking appropriate
antibiotic therapy for sore throat
-Neck pain and swelling
-Septic embolism
Lemmiere’s syndrome
Lab results
WBC > 15,000 cells/µl
Chest x-ray and/or CT may show evidence of pulmonary emboli
Neck CT shows internal jugular thrombophlebitis
Infection is usually caused by the anaerobic bacterium Fusobacterium necrophorum.
Lemmiere’s syndrome treatment
Treatment usually involves 4 weeks of antibiotics that have anaerobic coverage, such as beta-lactams with beta-lactamase inhibitors (e.g., ampicillin-sulbactam), clindamycin, or carbapenems
Influenza prophylaxis
Identification of cases of influenza within a long-term care facility should prompt early institution of prophylactic antiviral therapy to all residents (even those previously vaccinated) during the outbreak.
Strongyloidiasis clinical presentation
• Can be asymptomatic with peripheral eosinophilia
Gastrointestinal
• Abdominal pain mimicking duodenal ulcer, but pain worse with eating
• Chronic enterocolitis and malabsorption with high worm burden
Pulmonary
• Migration or larvae can cause dry cough, hemoptysis, dyspnea, and wheezing (often misdiagnosed as asthma)
• Fever with mild pneumonitis (can resemble pneumonia)
Skin
• Serpiginous and raised erythematous track (larva currens or “running” larva)
• Severe pruritus (ground itch)
Hyperinfection syndrome (due to autoinfection) leading to multiorgan dysfunction and possible septic shock.
Strongyloidiasis diagnostic test
• Stool samples can confirm but are frequently negative
• Many patients require serology tests (ELISA IgG antibody), endoscopy for duodenal biopsy or aspirate, or string test (Entero-Test)
Strongyloidiasis treatment
1st line: Ivermectin
2nd line: Albendazole
Syphilis post exposure prophylaxis
A patient exposed within 90 days of diagnosis of primary, secondary, or early latent syphilis in a sex partner
⏩⏩should receive treatment (even if the patient is seronegative for syphilis).
A patient exposed >90 days after diagnosis of primary, secondary, or early latent syphilis in a sex partner
⏩⏩should undergo serologic testing and also receive treatment if results are not immediately available or follow-up is uncertain.
MAC introduction
-Mycobacterium avium complex (MAC) is the most common cause of non- tuberculous mycobacteria (NTM) disease.
-MAC is ubiquitous and can be found in aerosolized water, piped hot water systems (eg, household and hospital water supplies, bathrooms), house dust, soil, birds, and farm animals.
-It can contaminate or colonize patients’ sputum, especially in those who are immunocompromised or with underlying lung disease (eg, chronic obstructive pulmonary disease [COPD]).
MAC presentation and diagnosis
The presentation can be similar to M tuberculosis (MTB) infection, and sputum can stain positive for acid-fast bacilli.
The diagnosis requires
1)clinical (chest x-ray with nodular or cavitary lesions, or CT with multifocal bronchiectasis and nodules)
2)microbiologic (>2 positive sputum cultures for MAC, 1 positive culture from bronchial wash/lavage, or lung biopsy with consistent findings and positive culture) criteria with the exclusion of other relevant conditions.
MAC treatment
Treatment in confirmed cases includes at least a year of combination therapy with a macrolide (eg, clarithromycin, azithromycin), ethambutol, and a rifamycin (eg, rifampin, rifabutin).
HSV encephalitis
Presentation
• Rapid onset (<1 week) of fever & headache
• Focal neurologic deficits (eg, cranial nerve palsies, hemiparesis, ataxia)
• Mental status changes & seizures
HSV encephalitis
Investigation
• CSF may be HSV PCR positive & show lymphocytic pleocytosis
• CT or MRI may be normal or show temporal lobe abnormalities
• EEG with high amplitude slow waves in >80% of patients
Invasive aspergillosis
Typically occurs in the setting of a severely immunocompromised state.
Patients commonly have fever, pleuritic chest pain, and hemoptysis; imaging often reveals nodular disease with ground-glass opacities (Halo sign) or cavitary lesions with air fluid levels (Air crescent sign). Diagnosis is usually made with sputum fungal stain and culture and serum fungal biomarkers (eg, galactomannan, beta-D-glucan).
A positive serum galactomannan assay has a specificity >75%.
Treatment with Voricanazole.
Acute radiation pneumonitis
Patients receiving thoracic or neck irradiation are at risk for acute radiation pneumonitis, which usually presents with antibiotic-nonresponsive pneumonia 4-12 weeks after radiation exposure. Treatment for acute disease includes prednisone for 2 weeks followed by a gradual taper over 3-12 weeks.